01 1AbbVie Inc
01 1ERYTHROMYCIN BASE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-05-09
Pay. Date : 2013-09-25
DMF Number : 27155
Submission : 2015-11-10
Status : Active
Type : II
20
Abbvie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ERYTHROMYCIN BASE, with a corresponding US DMF Number 27155.
Remarkably, this DMF maintains an Active status since its submission on November 10, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 09, 2016, and payment made on September 25, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
